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Received November 28, 2016; accepted January 26, 2017AbstractBackground: Gestational diabetes is defined as glucose intolerance which is first recognized in pregnancy. Oral glucose tolerance test (OGTT)
is the cornerstone in diagnosing gestational diabetes. Placental elasticity evaluation is relatively new concept and is principally used for
research purposes. We aimed to find any relation between placental elasticity evaluation and patients of gestational diabetes diagnosed by 75 g
OGTT.
Methods: There were 91 patients took part in study, forming two groups as gestational diabetic patients (21 patients) and control group
(70 patients). Elasticity of placenta was determined by acoustic radiation force impulse technology utilized by two blinded radiology specialists.
Results: We were not able to find any correlation between 75 g OGTT values and placental elasticity measurements (p > .05). Also placental
elasticity was not found to be significantly different in two groups (p > .05).
Conclusion: Placental elasticity measurement on the 24the28th weeks does not seem to be a marker for identification of gestational diabetes.
Copyright © 2017, the Chinese Medical Association. Published by Elsevier Taiwan LLC. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Diabetes is the most common complication of pregnancy.
Depending on the time of diagnosis, women with diabetes can
be classified as pre-gestational or gestational diabetes. Gesta-
tional diabetes mellitus (GDM) is defined as glucose intoler-
ance with onset during pregnancy, with no known previous
history.1 Prevalence of GDM is around 5e10%, with an in-
crease of about 40% between 1989 and 2004.2Conflicts of interest: The authors declare that they have no conflicts of interest
related to the subject matter or materials discussed in this article.
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license (http://creativecommons.org/licenses/by-nc-nd/4.0/).OGTT is one of the most recommended ways of testing
insulin tolerance of a pregnant patient who has not been
diagnosed as diabetic prior to pregnancy, according to criteria
of the American College of Obstetrics and Gynecology
(ACOG) and other associations such as the American Diabetes
Association (ADA).3,4 Testing can be done either with the one
step testing approach such as 75 g OGTT testing, or the two
step testing approach with initial 50 g OGTT testing followed
by a 100 g OGTT if needed.
Acoustic radiation force imaging (ARFI) is an ultrasonog-
raphy based technique of propagation of acoustic waves in
attenuating tissues to establish values of elasticity. With
increasing acoustic frequencies, the tissue does not respond fast
enough to the transitions between positive and negative pres-
sures. With this technique, however, we have more insightfulsevier Taiwan LLC. This is an open access article under the CC BY-NC-ND
Fig. 1. Sample measurement for ARFI and placenta elasticity.
Fig. 2. Sample measurement on calculating resistivity index from placenta.
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ogy is applied. The development of ARFI lead to some
placental research performed on mostly pre-eclamptic patients;
there even has been a recent study done on patients with
GDM.5,6
Our aim is to find any correlation between placental elas-
ticity and GDM screening results from 75 g OGTT. To the best
of our knowledge, this will be the first study done with 75 g
testing, to identify a different approach to GDM testing.
2. Methods
This was a prospective single-blinded caseecontrol study
done on Baskent University Istanbul Education and Research
Hospital between September 2015 and October 2016. During
the 24the28th week of pregnancy, patients were asked to have
an ARFI testing performed on their placental tissues. Patients
with multiple pregnancies, placenta located on the posterior
side of the uterine wall, patients with other systematic disorders
such as pre-gestational diabetes, hypertension, and rheumato-
logical diseases are excluded from the study. A total of 91 pa-
tients agreed to participate, and provided appropriate consent.
GDM testing was done with 75 g oral glucose solution. A
diagnosis of GDM was established when any of the following
results were obtained: fasting 92 mg/dl (5.1 mmol/L), 1 h
glucose level 180 mg/dl (10.0 mmol/L), or 2 h glucose level
153 mg/dl (8.5 mmol/L). Patients diagnosed with GDM
were initially and if possible treated only with nutritional
therapy. If nutritional therapy was not effective or inadequate
for achieving the target glucose levels (fasting 95 mg/dl, 1 h
140 mg/dl, 2 h 120 mg/dl), then insulin therapy was
initiated following consultation with an endocrinology
specialist.
Two blinded radiologists with more than 10 years experi-
ence each in the field participated in this study by doing the
ARFI examination on the day of GDM testing. The radiolo-
gists were completely unaware of patient glucose testing re-
sults as sonographic examinations were performed in the first
hour interval of the OGTT process. We used an Acuson S2000
Ultrasound System (Siemens, Erlangen, Germany) with a C6-
1Mhz convex probe for color Doppler ultrasonography (CDU),
ARFI and resistivity index measurements. Placental mea-
surements were obtained with patients lying on their backs.
Following initial evaluation of placental maturation, resistivity
index measurement was done from the arterial flow sample
points on the peripheral part of the placenta using CDU. A
region of interest (ROI) box was used to acquire standard
1 cm2 areas for ARFI measurement, based on the umbilical
cord insertion point and two other regions which were at least
2 cm away from the insertion point. Measurements were done
on the sagittal plane from areas that are clearly seen by
performer. Special attention was devoted to not having any
vessel formation inside of the ROI during measurement. The
mean of three measurements was calculated and used for
statistical purposes. Pictures showing an example of how to
measure elasticity and placental resistivity index have been
presented below (Figs. 1 and 2).Statistical Package for the Social Sciences (SPSS) version
23.0 (IBM Co, Chicago IL, USA) was used for statistical
analyses. ManneWhitney U-test, independent sample t test
and Pearson's correlation tests were used where appropriate. A
p value < .05 was considered to be statistically significant.
Baskent University IRB department provided approved this
study, with id number of KA16/267.
3. Results
Patients were divided into two groups. Patients with GDM
were referred to as the study group, with 21 patients enrolled
whereas patients with normal OGTT values were referred to as
the control group, with 70 patients enrolled. The incidence of
GDM in the whole group was found to be 23%. The mean age
of the study group was 32.60, and the mean age of the control
group was 29.32 with a significant difference from study group
Table 1
Comparing means of relevant pregnancy and birth information for patient
groups.
Study group
n ¼ 21
Control group
n ¼ 70
p
Age 32.60 ± 4.71 29.32 ± 4.24 .013
Body Mass Index (BMI) of
patients on evaluation day
29.25 ± 1.86 29.15 ± 2.28 .887
Gravidity 1.38 ± .64 1.47 ± .60 .632
Parity .27 ± .46 .28 ± .53 .931
Gestational weeks at birth 37.40 ± .828 38.06 ± 1.69 .125
Birth weight (gr) 3350 ± 82 3169 ± 436 .143
Mean APGAR values
on 1st minute
8.07 ± .961 8.18 ± 1.082 .717
Mean APGAR values
on 5th minute
9.47 ± .743 9.40 ± .756 .765
Gestational weeks at
ARFI measurement
24.80 ± .775 24.88 ± 1.58 .852
Significant values are given in bold.
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outlined in Table 1.
ARFI study results (placental elasticity) and placental re-
sistivity index result of patients depending on their groups are
listed in Table 2. Mean placental elasticity values for the study
group and control group are 1.28 ± .61 and 1.17 ± .57,
respectively. No significant difference found between these
two values ( p ¼ .549). Mean placental resistivity index values
for study group and control group are .46 ± .19 and .47 ± .11,
respectively; additionally, also with resistivity index, there is
no significant difference between these two values ( p ¼ .941).
4. Discussion
The prevalence of patients with GDM is on the rise,
especially over the last decade. A recent study from a
geographically similar area to our own found an incidence of
29.9% among the pregnant population and they expressed the
relation between higher prevalence of GDM with increasing
age.7 Our findings showed a significant age difference between
those patients with GDM and those without, with an incidence
of 23% in a relatively small population.
Although placental elasticity quantification is a recent
development in obstetric issues, this technology had been used
for some years in other organs such as the liver, thyroid and
breast tissue. In addition, this technology has been proven safe
to use for obstetrical purposes.8 There are some reports pre-
senting the use of ARFI in pregnant patient populations such
as patients with pre-eclampsia. It has been found that placental
elasticity is significantly decreased (described as increase in
placental stiffness) in patients with hypertensive disorder and
intrauterine growth restriction both ex vivo and in vivo.9,10Table 2
Mean elasticity values of placenta and placental resistivity index for both
groups.
Study group
n ¼ 21
Control group
n ¼ 70
p
Placental elasticity (m/sn) 1.28 ± .61 1.17 ± .57 .549
Resistivity index (m/sn) .46 ± .19 .47 ± .11 .941Even though some authors reported the presence of focal ne-
crosis and thickening of the villous trophoblastic basement
membrane as a histopathological finding and elevated stiffness
in patients with GDM, our findings suggest that there is no
difference in elasticity between patients with GDM and those
without.5,11 Also, there is no correlation between values of
elasticity and glucose levels.
Takako et al. found no difference of placental elasticity for
patients grouped under collagen diseases and diabetes melli-
tus, which includes both gestational and pre-gestational dia-
betic patients in their study, even though they expected to find
placental stiffness more than control group because abnormal
glucose tolerance and collagen disorders are known causes of
inflammatory changes.12 Our results showed similarity with
the afore-mentioned study.
In their study Yu¨ksel et al. found a significant difference of
the mean placental elasticity between patients with GDM
(established by a 50 g OGTT following a 100 g OGTT) and the
control group ( p < .001). It is understood that they used strain
elastography where one needed to apply pressure to accom-
plish measurement; thus, it is more likely to have inter
observer differences in that technique. We chose to use shear
wave elastography for our study as difference. The reason of
this discrepancy in results between our study and Yu¨ksel et al.'s
study could be because the lack of standardized measurement
system in placental elasticity and also Yu¨ksel et al. used a two-
step approach on diagnosing GDM. The differences of our
study from its predecessor studies are having radiologist team
blinded and using a one-step approach on diagnosis of GDM.
There were several major limitations to our study, including
not performing a histopathological examination for placental
tissues and the number of patients in groups, especially the
study group, could be more than what we have to make more
precise predictions. Even though our patient population has
similar BMI results for both groups, possible results from a
future study can be adjusted depending on patients for
different sized subcutaneous fatty tissues. Further larger
studies needed to fulfill this hypothesis whether ARFI is useful
in identifying elasticity to help diagnose GDM or not.
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